<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03146975</url>
  </required_header>
  <id_info>
    <org_study_id>Beta defensins in periodontics</org_study_id>
    <nct_id>NCT03146975</nct_id>
  </id_info>
  <brief_title>Effects of Gum Disease Treatment on Host Defense Factors</brief_title>
  <acronym>PETREBED</acronym>
  <official_title>Effects of Non-surgical Periodontal Treatment on Gingival Beta Defensins in Different Clinical Conditions : a Short-term Clinica Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of Minas Gerais</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of Minas Gerais</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Human immune system produces many different factors, which will influence health-disease&#xD;
      statuses. This partially explains why under similar conditions only some people become sick.&#xD;
      Therefore, specific analyses of such factors in healthy and diseased patients are crucial for&#xD;
      a better knowledge about diseases development and successful treatments. Human beta defensins&#xD;
      (hBD) may have a key role in patient's susceptibility to gum diseases. In the lab, high&#xD;
      levels of sugar (glucose) could inhibit their expression and contribute to the occurrence of&#xD;
      infections associated with diabetic wounds. This study will evaluate if treatment of the most&#xD;
      common gum disease in adults influences production of beta defensins by gingiva. Also,&#xD;
      clinical improvements and treatment effects on blood glycemic levels will be monitored&#xD;
      throughout a 2-month period. Patients with or without gum diseases and with or without&#xD;
      diabetes mellitus will be able to participate. After a complete oral examination to determine&#xD;
      periodontal status, gingival fluid samples will be collected using paper strips. These&#xD;
      samples will be collected before and also two-months after oral treatment and will be&#xD;
      analyzed by an immune-enzymatic test named ELISA (Enzyme-Linked Immunosorbent Assay). In&#xD;
      weekly sections, one trained specialist will performed treatment of gum diseases under local&#xD;
      anesthesia using hand-instruments. Researchers hypothesized that a) levels of defensins would&#xD;
      be lower in the presence of periodontal disease when compared to a healthy periodontal&#xD;
      condition; b) diabetes would influence production of these immune protective factors; and c)&#xD;
      treatment would provide a greater beneficial amount of defensins.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 2, 2014</start_date>
  <completion_date type="Actual">June 28, 2017</completion_date>
  <primary_completion_date type="Actual">June 20, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in beta defensins 1, 2 and 3</measure>
    <time_frame>Baseline and 60 days</time_frame>
    <description>Increase in the expression of beta defensins 1, 2 and 3 in gingival crevicular fluid samples</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in periodontal pocket depth</measure>
    <time_frame>Baseline and 60 days</time_frame>
    <description>Reduction in mean periodontal pocket depth</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in blood glycemic levels</measure>
    <time_frame>Baseline and 60 days</time_frame>
    <description>Reduction in blood glucose levels and levels of glycated hemoglobin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in percentage of diseased sites</measure>
    <time_frame>Baseline and 60 days</time_frame>
    <description>Reduction in the percentage of sites showing PPD&gt;4mm and/or bleeding on probing</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Periodontitis</condition>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Healthy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Periodontitis without diabetes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Periodontitis compensated diabetes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Periodontitis decompensated diabetes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Compensated diabetes non periodontitis</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Decompensated diabetes non periodontitis</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Non-surgical periodontal treatment</intervention_name>
    <description>Quadrant-wise ultrasonic debridement followed by manual scaling and root planing under local anesthesia provided in weekly sections. Oral hygiene instructions.</description>
    <arm_group_label>Periodontitis compensated diabetes</arm_group_label>
    <arm_group_label>Periodontitis decompensated diabetes</arm_group_label>
    <arm_group_label>Periodontitis without diabetes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Periodontally healthy individuals: at least 15 natural teeth, periodontal pocket depth&#xD;
             (PPD) ≤ 3mm e absence of bleeding on probing.&#xD;
&#xD;
          -  Periodontitis individuals: at least 15 natural teeth and at least 4 teeth with one or&#xD;
             more periodontal sites showing combined PPD ≥ 4mm and clinical attachment level (CAL)&#xD;
             ≥ 3mm.&#xD;
&#xD;
          -  Compensated diabetic individuals: compensated type 2 diabetes mellitus&#xD;
&#xD;
          -  Decompensated diabetic individuals: decompensated type 2 diabetes mellitus (glycated&#xD;
             hemoglobin HbA1c &gt;7%)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Past or actual systemic diseases other than diabetes type 2 in the diabetic groups&#xD;
&#xD;
          -  Gingivitis&#xD;
&#xD;
          -  Gingival overgrowth&#xD;
&#xD;
          -  Necrotizing periodontal diseases&#xD;
&#xD;
          -  Pregnant or lactating&#xD;
&#xD;
          -  smokers or former-smokers&#xD;
&#xD;
          -  medication that can influence periodontal status or host response to periodontal&#xD;
             therapy&#xD;
&#xD;
          -  periodontal therapy in the past 6 months from baseline&#xD;
&#xD;
          -  use of systemic or local antibiotics or anti-inflammatory drugs within 3 months prior&#xD;
             baseline&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fernando O Costa, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dean periodontics department</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Federal university of minas gerais</name>
      <address>
        <city>Belo Horizonte</city>
        <state>Minas Gerais</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <study_first_submitted>May 8, 2017</study_first_submitted>
  <study_first_submitted_qc>May 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 10, 2017</study_first_posted>
  <last_update_submitted>June 28, 2017</last_update_submitted>
  <last_update_submitted_qc>June 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of Minas Gerais</investigator_affiliation>
    <investigator_full_name>Fernando O Costa</investigator_full_name>
    <investigator_title>Head of periodontology</investigator_title>
  </responsible_party>
  <keyword>Beta-defensins</keyword>
  <keyword>Chronic periodontitis</keyword>
  <keyword>Diabetes mellitus</keyword>
  <keyword>Non-surgical periodontal therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individual participant data will not be shared. Only data without identification will be submitted to statistical analysis.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

